1-3 of 3
Yuh Min Chook
Close
Sort by
Journal Articles

Familial Thrombocytopenia-Associated Germline ETV6 P214L Mutation Results in XPO1-Mediated Nuclear Export

Michael McCONVILLE, Toby Thomas, Catherine Valadez, Ryan Beckner, Yuh Min Chook, Stephen Chung, Glen Liszczak
Journal: Blood
Blood (2023) 142 (Supplement 1): 1298.
https://doi.org/10.1182/blood-2023-182269
Published: 2023
Journal Articles

Next Generation XPO1 Inhibitor Shows Improved Efficacy and In Vivo Tolerability in Hematologic Malignancies

Zachary A. Hing, BS, Ho Yee Joyce Fung, BA, Parvathi Ranganathan, PhD, Shaneice Mitchell, BS, Dalia El-Gamal, PhD, Jennifer A. Woyach, MD, Katie Williams, MS, Virginia M. Goettl, DVM, PhD, Jordan L. Smith, BS, Xueyan Yu, Xiaomei Meng, Qingxiang Sun, PhD, Tolga Cagatay, PhD, John B. MacMillan, PhD, Amy M. Lehman, MAS, David M. Lucas, PhD, Erkan Baloglu, PhD, Sharon Shacham, Michael Kauffman, MD PhD, John C. Byrd, MD, Yuh Min Chook, PhD, Ramiro Garzon, MD, Rosa Lapalombella, PhD
Journal: Blood
Blood (2015) 126 (23): 317.
https://doi.org/10.1182/blood.V126.23.317.317
Published: 2015
Journal Articles

Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia

Rosa Lapalombella, Qingxiang Sun, Katie Williams, Larissa Tangeman, Shruti Jha, Yiming Zhong, Virginia Goettl, Emilia Mahoney, Caroline Berglund, Sneha Gupta, Alicia Farmer, Rajeswaran Mani, Amy J. Johnson, David Lucas, Xiaokui Mo, Dirk Daelemans, Vincent Sandanayaka, Sharon Shechter, Dilara McCauley, Sharon Shacham, Michael Kauffman, Yuh Min Chook, John C. Byrd
Journal: Blood
Blood (2012) 120 (23): 4621–4634.
https://doi.org/10.1182/blood-2012-05-429506
Published: 2012
Includes: Supplemental data